RSV-Impfung - was Sie wissen sollten

The burden of disease caused by respiratory syncytial virus (RSV) is particularly high in infants and small children, but also in older adults and those with severe comorbidities. Two protein-based vaccines and one mRNA vaccine are available for vaccination in Germany. The Standing Committee on Vaccination (STIKO) recommends a single RSV vaccination with one of these vaccines as a standard vaccination for all 75-year-olds and older and furthermore a single RSV vaccination as an indication vaccination for people aged 60 to 74 who live in a care facility or suffer from severe underlying disease, if possible before…